L-Tyrosine — Research Profile

Evidence for cognitive enhancement under normal, non-stressed conditions is limited. ^[2] Tyrosine works best when catecholamine (dopamine/norepinephrine) stores are depleted by stress, sleep deprivation, or demanding tasks. ^[5] If you are well-rested and unstressed, tyrosine may provide minimal additional benefit.

L-Tyrosine is preferred. N-Acetyl L-Tyrosine (NALT) is more water-soluble, making it popular in drink mixes, but it is poorly deacetylated in the body — much of it is excreted unused. L-Tyrosine has better evidence for raising brain tyrosine and catecholamine levels.

Yes. The combination is popular in nootropic stacks. Caffeine increases catecholamine release (short-term boost), while tyrosine provides the building blocks to replenish catecholamine stores (sustained support). Together they may provide longer-lasting alertness. Add L-theanine for an even smoother experience.

Free-form L-tyrosine is the form used in essentially all of the human trials, including the cold-exposure working-memory study, the 2 g decision-making study, and the 100 mg/kg/day anorexia trial. N-acetyl L-tyrosine (NALT) is often marketed for better absorption, but it was not the form tested in these studies and has not been shown to reproduce their cognitive results. On current evidence, plain L-tyrosine is the better-supported choice.

The strongest evidence is for protecting cognition under acute stress: 150 mg/kg preserved working memory during cold-water immersion, and the same dose improved core-temperature maintenance during whole-body cooling in older adults. A review concluded tyrosine enhances cognition only when neurotransmitter function is intact and dopamine or norepinephrine is temporarily depleted, and found little support for treating clinical disorders or boosting exercise. It is best understood as a situational cognitive buffer, not a broad enhancer.

There is no official recommended intake for supplemental tyrosine. Acute stress-and-cognition trials typically used a single weight-based dose of 100-150 mg/kg (roughly 7-11 g for a 70 kg adult), while a decision-making study used a flat 2 g dose and a 3-week anorexia trial used 100 mg/kg/day. Doses are matched to a task or stressor rather than taken as a fixed daily amount.

Timing is anchored to the demanding event, not the clock: trials dosed tyrosine roughly 30-60 minutes before the stressor or task. The decision-making study measured effects 60 minutes post-dose, and the cold-exposure studies had participants take it immediately before immersion. Taken well after the challenge has passed, there is no reason to expect the same benefit.

In controlled trials tyrosine was well tolerated — the 3-week 100 mg/kg/day anorexia study explicitly reported no side effects. Its common side effects are not well characterized: reference monographs note there is not enough research to define its typical adverse effects, though one caution is that in people prone to migraines tyrosine may trigger migraine headaches and stomach upset. Serious reactions appear to be rare.

The most serious concern is monoamine oxidase inhibitors (MAOIs), used for depression or Parkinson's disease: combined with tyrosine they can cause a severe increase in blood pressure — a hypertensive crisis that can lead to heart attack or stroke. Tyrosine may also interact with synthetic thyroid hormones such as levothyroxine, because it is a precursor for thyroid hormone synthesis and could raise hormone levels too high. Anyone taking these medications should get medical advice before supplementing.

The people most likely to benefit are those facing short-term stressors that deplete dopamine and norepinephrine — such as cold, sleep loss, or heavy cognitive load — since that is where trials show preserved working memory and performance. It is not well supported for routine daily cognition or athletic performance. People taking MAO inhibitors or thyroid medication should avoid it or seek medical guidance, and those with hyperthyroidism or Graves disease are advised to avoid tyrosine supplements.

L-Tyrosine is used acutely rather than as a daily buildup supplement: in the studies where it helped, a single dose was taken 30-60 minutes before a stressor or cognitive task. In one trial, 2 g reduced physiological arousal and altered decision-making measured 60 minutes after dosing, and in cold-exposure work the dose was consumed immediately before immersion. Effects are tied to that acute window, not to weeks of accumulation.

Long-term daily safety has not been well characterized because most tyrosine trials used single acute doses. The longest controlled data comes from a 3-week crossover in hospitalized anorexia patients taking 100 mg/kg/day, where no side effects were reported. Beyond a few weeks the safety profile is simply not established, and reference monographs note there is not enough research to define its common effects with chronic use.

No tolerable upper intake level has been established for supplemental tyrosine. Controlled trials have given acute doses as high as 150 mg/kg — roughly 10-11 g for a 70 kg adult — without serious adverse effects. The more important ceiling is pharmacological rather than nutritional: combined with a monoamine oxidase inhibitor (MAOI), tyrosine can trigger a severe rise in blood pressure, or hypertensive crisis, so the amount alone is not the only safety consideration.

Tyrosine is often stacked with caffeine and other ingredients in pre-workout blends, but there is little controlled evidence that any specific supplement pairing outperforms tyrosine alone. A review of the cognitive literature found the amino acid does not reliably enhance physical exercise, so stacking it for that purpose is not well supported. Its clearest documented benefit is standalone use before an acute stressor, not as part of a combination.

Tyrosine is a single amino acid, so there is no active-compound percentage to standardize the way there is for a botanical extract; the practical checks are purity, an accurate labeled dose, and third-party testing. Nearly all of the cognition and cold-stress trials used plain free-form L-tyrosine, so that is the form with the best evidence behind it. N-acetyl L-tyrosine (NALT) is marketed as a more soluble alternative, but it was not the form validated in these studies.